Table 4.
Description of PRO and ClinRO data at baseline in the mITT population
| Variable | mITT population (N = 280) |
|---|---|
| Pruritus NRS score | |
| n | 261 |
| Mean (SD) | 7.46 (2.18) |
| Sleep-Loss Scale score | |
| n | 262 |
| Mean (SD) | 2.04 (1.13) |
| POEM score | |
| n | 279 |
| Mean (SD) | 20.35 (6.21) |
| DLQI score | |
| n | 279 |
| Mean (SD) | 14.22 (7.18) |
| HADS-Anxiety score | |
| n | 280 |
| Mean (SD) | 7.50 (4.70) |
| HADS-Depression score | |
| n | 280 |
| Mean (SD) | 5.52 (4.21) |
| IGA score, n (%) | |
| Moderate | 182 (65.0%) |
| Severe | 98 (35.0%) |
| Body surface area | |
| n | 280 |
| Mean (SD) | 42.79 (22.43) |
| EASI score | |
| n | 280 |
| Mean (SD) | 27.41 (11.75) |
mITT modified intent-to-treat, SD standard deviation, Pruritus NRS Pruritus Numeric Rating Scale, POEM Patient Oriented Eczema Measure, DLQI Dermatology Life Quality Index, HADS Hospital Anxiety and Depression Scale, IGA Investigator Global Assessment, EASI Eczema Area and Severity Index